MusclePharm Sees Expanded Opportunity In Light Of FDA's Ban On Ingredient DMAA

DENVER, May 3, 2012 /PRNewswire/ -- MusclePharm Corporation (OTCBB: MSLP), a nutritional supplement company focusing on all categories of an active lifestyle, today said that, in light of yesterday's FDA ban on the substance DMAA, which is not used in MusclePharm products, it expects to capture a wider market share, particularly for the company's pre-workout supplement Assault™, which is the only pre-workout product on the market that is certified by both NSF International and Informed Choic...continued MSLP

URL: http://www.investorpoint.com/news/OTCBULLB/50947547/